161 related articles for article (PubMed ID: 16088366)
1. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
2. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
3. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
[TBL] [Abstract][Full Text] [Related]
4. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
[TBL] [Abstract][Full Text] [Related]
5. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
Nelson KE; Vlahov D; Galai N; Astemborski J; Solomon L
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S201-5. PubMed ID: 7865301
[TBL] [Abstract][Full Text] [Related]
6. Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson KE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S265-8. PubMed ID: 7865315
[TBL] [Abstract][Full Text] [Related]
7. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.
Harrison K; Vlahov D; Jones K; Charron K; Clements ML
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502
[TBL] [Abstract][Full Text] [Related]
8. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
9. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
10. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
11. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.
Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB
Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
[TBL] [Abstract][Full Text] [Related]
14. Willingness of Chinese injection drug users to participate in HIV vaccine trials.
Yin L; Zhang Y; Qian HZ; Rui B; Zhang L; Zhu J; Guan Y; Wang Y; Li Q; Ruan Y; Shao Y
Vaccine; 2008 Feb; 26(6):762-8. PubMed ID: 18191881
[TBL] [Abstract][Full Text] [Related]
15. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
16. The dynamics of injection drug users' personal networks and HIV risk behaviors.
Costenbader EC; Astone NM; Latkin CA
Addiction; 2006 Jul; 101(7):1003-13. PubMed ID: 16771892
[TBL] [Abstract][Full Text] [Related]
17. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
Giocos G; Kagee A; Swartz L
AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
19. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
20. Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.
Evangeli M; Kafaar Z; Kagee A; Swartz L; Bullemor-Day P
AIDS Care; 2013; 25(7):910-4. PubMed ID: 23216424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]